Project Grant R01HL169893
Award Date
5/1/25
Completion Date
2/28/30
Dollars Obligated
$691K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This federal Project Grant award of $524,390 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund research to examine the relationship between sleep health, circadian timing, and cardiometabolic risk in adolescents with type 1 diabetes. The award will support a randomized clinical trial to evaluate the impact of a combined sleep health and circadian timing...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) provides $752,991 to the University of Cincinnati to empirically test the sleep health socioecological framework. The study aims to define how multi-level socioecological factors, including understudied risk factors like racism, housing insecurity, screen media use, and toxic stress, predict inequities in early childhood sleep...
This $1,981,077 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund research to investigate the molecular mechanisms underlying the circadian regulation of cardiac ion channel genes and the impact of circadian alignment and misalignment on cardiac electrophysiology and arrhythmia susceptibility. The research aims to elucidate the cis-regulatory elements responsible for the circadian regulation...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,093,397 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Michigan. The grant aims to develop novel statistical and machine learning methods to fully exploit continuous glucose monitoring (CGM) and ambulatory blood pressure monitoring (ABPM) data for precision phenotyping of glycemic and cardiovascular measures related to obstructive sleep apnea. The proposed...
This Project Grant award of $684,116 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a mechanistic study to examine how improving sleep regularity affects glycemic control and cardiovascular disease risk in adults with type 1 diabetes. The study will conduct a 4-week behavioral sleep stability intervention with 80 participants, measuring changes in...
The federal Project Grant award R21HL175584, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), provides $133,410.00 to the University of Massachusetts Medical School (UMass Medical) to investigate the impact of sleep pathology on cardiac aging and cardiovascular disease risk. The two-year project, starting in September 2024 and ending in August 2026, will leverage a rare longitudinal dataset to assess the association...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $696,470 to the University of Denver to conduct research on the impact of prenatal maternal sleep on offspring cardiovascular disease risk. The 5-year project will objectively measure maternal sleep patterns across pregnancy and evaluate how they relate to maternal biological processes (stress, inflammation), infant growth and adiposity,...
This $821,982 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research to investigate sleep variability as a potential new risk factor for cardiovascular disease (CVD) in women. The grant, awarded to The Trustees of Columbia University in the City of New York, will leverage two racially and ethnically diverse cohorts of women to: 1) analyze the link between objectively-measured variable...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a 5-year, $655,655 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Northwestern University to investigate the physiological and behavioral basis of delayed sleep-wake phase disorder (DSWPD). The research aims to identify distinct DSWPD subtypes, understand the underlying differences in physiology and behaviors that impact sleep timing, and use these insights to inform the development of personalized treatment...
The federal Project Grant award K01HL177045 for $143,829.00, awarded by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to establish human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as models for studying how the intrinsic cardiomyocyte circadian clock impacts cell size and function. The overarching objectives are to 1) determine the mechanisms by which circadian regulation influences...